Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
66 hedge funds and large institutions have $57.2M invested in Applied Genetic Technologies Corporation in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 11 closing their positions.
1,119% more call options, than puts
Call options by funds: $1.34M | Put options by funds: $110K
15% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 20
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 71 → 66 (-5)
20% less capital invested
Capital invested by funds: $71.5M → $57.2M (-$14.3M)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$561K |
| 2 |
Two Sigma Investments
New York
|
+$556K |
| 3 |
Millennium Management
New York
|
+$496K |
| 4 |
Two Sigma Advisers
New York
|
+$440K |
| 5 |
JP Morgan Chase
New York
|
+$368K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$4.01M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.1M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$942K |
| 4 |
6CM
683 Capital Management
New York
|
-$930K |
| 5 |
PVI
Pura Vida Investments
New York
|
-$857K |
AGTC Hedge Fund Activity: Q4 2020 in Review
66 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2020, worth a combined $57.2M — down 20% from $71.5M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of AGTC and 6 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 23 added.
The largest buyer was BlackRock, adding an estimated $561K. The largest seller was Sofinnova Investments, exiting entirely with an estimated $4.01M sold.
- 66 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2020, down from 71 in Q3 2020.
- Funds reported $57.2M of Applied Genetic Technologies Corporation stock for Q4 2020, down 20% quarter-over-quarter.
- 6 funds opened new Applied Genetic Technologies Corporation positions in Q4 2020 and 11 closed out, a net change of -5 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q4 2020 was BlackRock, an estimated $561K added.
- The largest Applied Genetic Technologies Corporation seller in Q4 2020 was Sofinnova Investments, an estimated $4.01M sold.
Based on aggregated 13F filings for Q4 2020.